BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Advanced Bio-Surfaces, Inc. Reports Over 125 Successful Implants Of The OrthoGlide(TM) Medial Knee Implant


2/12/2007 12:30:49 PM

MINNEAPOLIS, Feb. 12 /PRNewswire-FirstCall/ -- Advanced Bio-Surfaces, Inc., (ABS) an orthopedic implant developer and manufacturer, announced today the successful completion of over 125 OrthoGlide Medial Knee implants in the USA.

"We're pleased to report this many clinically successful implants. By controlling the introduction of the product we've been able to support our implanting orthopedic surgeons during their first cases," said Dr. Jeff Felt, Chairman and CEO of Advanced Bio-Surfaces. "Surgeons implanting the OrthoGlide continue to share how pleased they are with the ease of implanting the device and their patient's satisfaction with the outcome."

Alan Markman, M.D., at TRIA Orthopedic Center in Minneapolis, MN is an experienced OrthoGlide implanter and proctors the training workshops. Dr. Markman said, "From an educator standpoint, the OrthoGlide procedure is easier to teach than the total knee replacements. From a surgeon perspective, I'm pleased that my patient's implanted with the OrthoGlide have experienced good pain relief, minimal swelling and near full range of motion. Based on my OrthoGlide experiences, I believe that these are the standard results surgeons can typically expect with this product."

One of the most experienced implanters of the OrthoGlide is David Esposito, M.D. practicing in Wilmington, North Carolina with the Carolina Sports Medicine and Orthopaedic Specialists. Dr. Esposito said, "The early clinical success of the OrthoGlide, as measured by patient's pain and function scores, have been exciting and consistent within the group of patients I have implanted." Dr. Esposito went on to say, "Surgeons are seeking to improve a patient's quality of life through a surgical intervention while minimizing the disruption to the surrounding tissues. My personal experience is that the OrthoGlide's minimally invasive surgical procedure does allow the patient to feel better sooner."

About Advanced Bio-Surfaces, Inc.

ABS is a privately held company dedicated to the development of innovative joint repair products. The company's first product, the OrthoGlide Medial Knee Implant, is intended for treatment of patients with moderate osteoarthritis of the medial compartment. The company received 510(k) clearance to market from the U.S. Food and Drug Administration (FDA) and CE mark notification from its Notified Body, in February 2006. For additional information contact Robert Siegfried at 952.912.5400.

Advanced Bio-Surfaces, Inc.

CONTACT: Robert Siegfried, VP, Finance and Administration of AdvancedBio-Surfaces, Inc., +1-952-912-5400



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES